Research reading
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale demand and the South Korea (KOR) to Netherlands (NLD) lane
Netherlands (NLD) reported $4.4B of blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale imports in 2024. South Korea (KOR) accounted for 4.2% of the observed market and reported $184.6M in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +35.7% buyer growth and +76.5% exporter growth. The page separates reported values from projections and indicators.
